WAM
27 Apr 2022, 05:10 GMT+10
BEIIJING, 26th April, 2022 (WAM) -- A Chinese inactivated vaccine against Omicron variants was approved for clinical trials by the National Medical Products Administration on Tuesday, according to Xinhua.
The vaccine, developed by the China National Biotec Group affiliated with Sinopharm, has been under research since December 2021, the company said.
Preliminary tests, such as safety evaluation in animals and immunogenicity research, showed that the vaccine can produce high neutralizing antibody titer against various variants including Omicron.
In the clinical trials, a randomised, double-blind and cohort study method will be adopted among people aged 18 and above that have inoculated two or three doses of COVID-19 vaccines to evaluate the safety and immunogenicity of the inactivated vaccine.
Get a daily dose of Beijing Bulletin news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Beijing Bulletin.
More InformationWASHINGTON, D.C.: On Friday, President Donald Trump announced that he was halting trade discussions with Canada due to its decision...
FRANKFURT, Germany: Germany has become the latest country to challenge Chinese AI firm DeepSeek over its data practices, as pressure...
SAN FRANCISCO, California: Under pressure from European regulators, Apple has revamped its App Store policies in the EU, introducing...
SAN FRANCISCO, California: A U.S. judge has dismissed a copyright lawsuit filed by 13 authors against Meta Platforms, the company that...
The US president still said that the tech billionaires attacks on him and his big, beautiful bill were not appropriate Donald Trump...
BEIJING, June 30 (Xinhua) -- In a workshop in the southwestern Chinese city of Chengdu, rows of fermentation tanks are filled with...
NEW YORK, New York - U.S. stock markets closed firmly in positive territory to start the week Monday, with the S&P 500 and Dow Jones...
WASHINGTON, D.C.: On Friday, President Donald Trump announced that he was halting trade discussions with Canada due to its decision...
LONDON, U.K.: A little-known investment fund based in the United Arab Emirates has emerged as the most prominent public backer of U.S....
SAN FRANCISCO, California: Across the U.S., a growing number of people are taking obesity treatment into their own hands — literally....
SAN FRANCISCO, California: Under pressure from European regulators, Apple has revamped its App Store policies in the EU, introducing...
NEW YORK CITY, New York: The U.S. dollar tumbled this week, hitting its lowest levels since 2021 against the euro, British pound, and...